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Abstract
Inflammatory disorders of the central nervous system such as multiple sclerosis and acute disseminated
encephalomyelitis involve an invasion of immune cells that ultimately leads to white matter demyelination,
neurodegeneration and development of neurological symptoms. A clinical diagnosis is often made when
neurodegenerative processes are already ongoing. In an attempt to seek early indicators of disease, we studied the
temporal and spatial distribution of brain modifications in experimental autoimmune encephalomyelitis (EAE). In a
thorough magnetic resonance imaging study performed with EAE mice, we observed significant enlargement of the
ventricles prior to disease clinical manifestation and an increase in free water content within the cerebrospinal fluid as
demonstrated by changes in T2 relaxation times. The increase in ventricle size was seen in the lateral, third and
fourth ventricles. In some EAE mice the ventricle size started returning to normal values during disease remission. In
parallel to this macroscopic phenomenon, we studied the temporal evolution of microscopic lesions commonly
observed in the cerebellum also starting prior to disease onset. Our data suggest that changes in ventricle size
during the early stages of brain inflammation could be an early indicator of the events preceding neurological disease
and warrant further exploration in preclinical and clinical studies.
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Introduction
Under normal physiological conditions, immunologically
competent CNS resident cells, such as microglia, or immune
cells derived from the peripheral circulation serve to protect the
CNS against potentially harmful infectious agents or traumatic
events [1–3]. Blood-borne immune cells, including memory T
cells, are limited to the leptomeningeal, perivascular and
ventricular cerebrospinal fluid (CSF) spaces [2,3]. In the
healthy brain, the CSF compartment appears to be the only site
where memory T cells localize to in the CNS [4], their presence
persisting for several years [3]. The CSF compartment indeed
assumes an important role for immune surveillance [5,6] as the
site where activated T cells can communicate with resident
antigen-presenting cells [7,8]. The passage of CD4+ memory T
cells into the CSF compartment occurs following their
extravasation via microvascular structures of the choroid
plexus into the cerebral ventricles or alternatively via
postcapillary venules into leptomeningeal and perivascular
Virchow–Robin (VRS) spaces [5].
Although CD4+ memory T cells can easily enter the CSF
compartment, their entry into the CNS parenchyma is restricted
by the blood brain barrier (BBB), which consists of the cerebral
vessel endothelial cells and surrounding glia limitans. During
autoimmune encephalomyelitis, such as occurs in multiple
sclerosis (MS), the BBB is transformed and its function altered,
e.g. by the action of several inflammatory molecules [9,10].
Following activation of the BBB, T cells now gain access to the
brain parenchyma via a multi-step process that involves
crossing both, the vascular endothelium and the glia limitans
[11]. This inflammatory cell invasion into the VRS precedes
perivascular cuffing that ultimately leads to inflammatory and
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demyelinating lesions. These prominent pathological patterns
have long been documented histologically in MS autopsy
material [12]. Specific pathological changes such as
enlargement of the VRS, can be detected in MS brains with
magnetic resonance imaging (MRI) [13], making it possible to
detect [14] and quantify [15] these changes during the
development of MS disease.
Recently, cryogenically-cooled 1H coils have started gaining
momentum in preclinical microscopic (micro) MR neuro- and
cardiovascular imaging due to an improved signal-to-noise ratio
compared to traditional room temperature 1H coils [16–18].
Using the experimental model of autoimmune
encephalomyelitis (EAE) and a cryogenically-cooled 1H coil, we
recently were able to detect and follow pathological changes in
the CNS prior to onset of clinically detectable disease signs
[19]. In this study we were able to define changes in the brain
of immunized mice that corresponded to cellular infiltrates in
immunohistology. Moreover, after Gd-DTPA administration we
observed that contrast agent (CA) distributed not only into
lesions but also into the ventricular compartment in most EAE
animals [19].
Here, we employed the cryogenically-cooled 1H coil to
identify both micro- and macroscopic changes prior to clinical
onset and during manifestation of disease in EAE using a
larger cohort of animals. To study microscopic changes, we
focused on the evolution of cerebellar lesions, which are the
most common pre-symptomatic lesions in the EAE. The main
macroscopic alteration in the EAE brain is a prominent and
sustained increase in cerebral ventricle size. We therefore
followed up changes in ventricle volume as well as T2
relaxation times of ventricular CSF (since this has been shown
to correlate with methods measuring direct water concentration
in the brain [20,21]) prior to and after clinical disease onset.
Material and Methods
Induction of EAE
Female SJL/J mice were purchased from Janvier (Janvier
SAS, Le Genest-St-Isle, France). For active EAE, 22 mice (12
weeks old) were immunized subcutaneously with 250 µg PLP
(Pepceuticals Ltd., UK) and 800 µg mycobacterium
tuberculosis H37Ra (Difco) in 200 µl emulsion containing equal
volumes of phosphate/buffered saline (PBS) and complete
Freunds adjuvant (BD-Difco), as previously described [22] 200
ng pertussis toxin (List Biological Laboratories, US) were
administered intraperitoneally at days 0 and 2. Six mice were
used as normal controls. An additional 6 mice were used for
sham immunizations; for this we employed the same protocol
used for EAE induction but omitted PLP. Mice were weighed
and scored daily as follows: 0, no disease; 1, tail weakness and
righting reflex weakness; 2, paraparesis; 3, paraplegia; 4,
paraplegia with forelimb weakness or paralysis; 5, moribund or
dead animal. Mice with a score of 2.5 or more received an
intraperitoneal injection of 200 µl glucose (5%) daily and mice
with a score of 3 for more than 24 hours were sacrificed.
Animals used as controls were healthy untreated mice. Animal
experiments were carried out in accordance with the guidelines
provided and approved by the Animal Welfare Department of
the LAGeSo State Office of Health and Social Affairs Berlin
(Permit G-0172/10: MR Bildgebung d. Therapieansätze - EAE
09.2010 - 09.2013).
Magnetic Resonance Imaging
Mice were imaged before EAE immunization and daily (at the
same time of day) between 5 and 18 days after active EAE
induction. MRI was performed using a 9.4 Tesla animal
scanner (Biospec 94/20 USR, Bruker Biospin, Ettlingen,
Germany) and a cryogenically-cooled quadrature-resonator
(CryoProbe, Bruker Biospin, Ettlingen, Germany). Mice were
placed on a water circulated heated holder to ensure constant
body temperature of 37 °C and kept anesthetized using a
mixture of isoflurane 1–1.5% (Abbott GmbH & Co. KG,
Wiesbaden, Germany), air and oxygen. Body temperature and
breathing rate were constantly checked by a remote monitoring
system (Model 1025, SA instruments Inc., New York, USA).
Horizontal and coronal fat suppressed turbo spin echo T2-
weighted TurboRARE (TE = 36 ms, TR = 3000 ms, matrix =
384 × 384, FOV = 1.8 cm, NEX = 2, coronal slices = 22, slice
thickness = 0.5 mm, scan time = 5 min, axial slices = 16, slice
thickness = 400 µm, scan time = 5 min) brain images were
acquired. Slice positioning was kept fixed through the
longitudinal brain examination: horizontal slices were
positioned parallel to the base of the brain, coronal slices were
positioned perpendicularly to horizontal slices and covering the
brain from the olfactory bulb/frontal lobe fissure to the cervical
spinal cord. For parametric mapping of the relaxation time T2 a
multislice-multi-echo (MSME) technique (TR = 1500 ms, matrix
= 256x 256, FOV = 1.8 cm, NEX = 2, slice = 1, scan time = 15
min) was used. For this purpose echo times (TE) ranging from
(10–80) ms were used to vary T2-weighting in increments of 10
ms. The slice was positioned horizontally using as reference
the horizontal TurboRARE geometry covering cortex, caudate
putamen, hippocampus, cerebellum and lateral, third and fourth
ventricles.
Brain Segmentation
Quantification of ventricle size was performed using FSL5.0
(FMRIB’s Software Library, www.fmrib.ox.ac.uk/fsl) [23–25]. All
T2-weighted images were corrected for bias field
inhomogeneity and cleared of non-brain tissue using the brain
extraction tool (BET) of FSL [26]. One brain image set was
chosen as reference and processed using an automated image
segmentation tool (FAST) to obtain a ventricle mask [27].
Subsequently all other brain images were registered to the
reference brain using FMRIB’s Linear Image Registration Tool
(FLIRT) to generate an inverse transformation matrix [28]. This
matrix was afterwards applied to the reference ventricles mask
to map the ventricle size of each animal. To investigate volume
changes in each ventricle separately a mask for each different
ventricle was generated starting from the ventricle reference
mask. The obtained masks were then used to calculate the
single ventricle volume as described above. Ventricle size was
calculated as total µl volume within segmented ventricles and
the ventricle volume changes was estimated as a ratio of each
day ventricle volume to pre immunization ventricle volume.
Ventricular Changes in Encephalomyelitis
PLOS ONE | www.plosone.org 2 August 2013 | Volume 8 | Issue 8 | e72841
Brain tissue volume was manually measured by three
independent investigators in 2 animals per group (EAE mice,
ventricle normalizing mice and control group), on 2 adjacent
slices where it was possible to clearly depict the lateral
ventricles and the caudate putamen, the most evident brain
regions subjected to volume changes. For each slice, the
parenchymal volume was calculated subtracting the volume of
the ventricles from the volume of the whole brain area.
MR Relaxometry
Maps of absolute T2 relaxation times were calculated by
pixel-wise mono-exponential fitting, implemented in an in-
house developed MATLAB program. To quantify the T2
relaxation times in the CSF within the ventricular compartment
for each obtained map, a mask of the ventricles cleared of the
choroid plexus was generated using the FAST tool of FSL. To
minimize the influence of partial volume effects generated from
neighboring brain tissue, we eroded the automatically
generated mask by two voxels. T2 relaxation time of the
ventricular CSF was calculated as the mean T2 relaxation time
for all pixels within the mask.
Data analysis
Three independent blinded investigators were involved in the
analysis of the MRI data. All data were thereafter statistically
analyzed using GraphPad Prism (GraphPad Software, Inc., La
Jolla, CA, USA). The onset of cerebellar lesions was
determined by manual inspection. With regards to the onset of
ventricle enlargement, a minimum of 10% volume increase
from the pre-immunization (baseline) volume was used as
threshold. The ventricle normalizing animals were defined as
those showing a 10% reduction from the maximum observed
ventricular volume. Differences between EAE mice and
controls regarding ventricular enlargement and T2 relaxation
time were analyzed by the student t-test. To compare the onset
of cerebellar lesions and ventricular enlargement with the onset
of disease we employed a paired t-test since these parameters
represent repeated measurements of the same individual mice
over time. A p-value of p<0.05 was considered to be
statistically significant. A log-rank (Mantel-Cox) test was used
to analyze the time-to-event curves and compare the onset of
clinical symptoms, cerebellar lesions and ventricle
enlargement.
Results
Ventricle enlargement before manifestation of
neurological disease
In this study we followed brain modifications during the
development of active EAE in a large group of mice (n=20).
The first distinct macroscopic change we observed on T2-
weighted images was an increase in cerebral ventricle size
without manifestation of clinical disease (Figure 1A, 1B). Figure
1A shows a representative mouse (mouse 8 in Figure 1B) in
which ventricle enlargement was detected two days before
start of symptoms (d -2). In this EAE mouse we also observed
a decrease in ventricle size, three days (d +3) following the
symptom onset, defined as the first day of evident motor
impairment (tail weakness). Figure 1B summarizes the time-
line for all investigated EAE mice and indicates the first day of
volume changes in the ventricles in relation to the symptom
onset post EAE induction (immunization with CNS antigen).
All immunized mice eventually developed symptomatic EAE.
The average day of disease clinical manifestation was 10.8 ±
1.1 (± S.D.) days post immunization, comparable to previous
studies [19]. 19 out of 20 mice studied showed an increase in
ventricle size and in 16 of these 19 animals, the ventricle
enlargement was observed prior to disease manifestation,
notably the increase could be detected even up to five days
prior to symptom manifestation (mouse 1). In two cases the
ventricle enlargement coincided with the symptom onset. On
average, EAE mice exhibited an increase in ventricle size 1.6
±1.2 (± S.D.) days before the first symptom.
Cerebellar lesion evolution during disease
development
Both hyperintense and hypointense lesions could be
detected in multiple brain areas prior to disease manifestation
in EAE, however, most commonly hyperintense lesions in the
cerebellum [19]. We here investigated the temporal changes of
these lesions by T2-weighted micro MRI, keeping our main
focus on the cerebellum (Figure 2). Figure 2A shows a
representative EAE mouse (mouse 7 in Figure 2B), in which
lesions were identified in the white matter of the cerebellum as
hyper-intense regions (Figure 2A, asterisks) on T2-weighted
images; these lesions were detected already 3 days before
clinical disease onset (d -3). The shape and spatial distribution
of these lesions changed over time, also involving other areas
of the arbor vitae (d -2 and d -1). Some lesions, especially
those surrounding small vessels, turned hypo-intense (Figure
2A, white arrows) and appeared to partially resolve two days
after the first neurological symptoms (d +2). Figure 2B
recapitulates the temporal differences between the time of first
appearance of cerebellar lesions and the time of first symptom
manifestation in all EAE mice. Out of 20 animals that
developed EAE, 18 showed pre-symptomatic cerebellar lesions
on average 2.5 (±1.09 S.D.) days before the first manifestation
of clinical signs. Lesion appearance could be observed up to 5
days before disease onset (mouse 1). With the exception of
two animals, that did not develop micro MRI visible pathology
within the cerebellum, EAE mice commonly manifested early
lesions at least one day before appearance of clinical
symptoms. Of note, the only mouse that developed clinical
disease but no evident changes on MRI (mouse 20) was not
only devoid of cerebellar lesions but also exhibited no ventricle
enlargement.
The average day of first ventricle size increase was 8.7 ± 2.7
days (± S.D.) post immunization (p.i.) and the average day of
first cerebellar lesion occurrence was 7.3 ± 2.8 days (± S.D.)
p.i., in comparison to the average day of clinical disease onset,
which was 10.8 days p.i. (see above) (Figure S1A). We next
wanted to determine the fraction of EAE mice undergoing each
of these events over the period of time after immunization. We
plotted time-to-event curves for first appearance of (i) clinical
signs, (ii) ventricular enlargement and (iii) cerebellar lesions
Ventricular Changes in Encephalomyelitis
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against the time span after immunization (Figure S1B). We
observed that both cerebellar lesions and ventricular
enlargement occurred significantly earlier than the appearance
of clinical signs (Figure S1B); cerebellar lesions vs. clinical
signs, p < 0.0001; ventricular enlargement vs. clinical signs, p =
0.0064.
Changes in clinical scores are preceded by changes in
ventricle size
Next we compared the changes in ventricle volume with EAE
signs and symptoms (weight and EAE score) during the
progression of disease. Hence, for each mouse, we
synchronized all 3 parameters (weight, clinical score and
ventricle volume) to the day of first neurological symptoms,
defined as time point 0 (Figure 3). The animal weight started
decreasing 3-4 days before disease manifestation and started
returning to normal 3-4 days after initiation of symptoms
(Figure 3A). The average score at peak of disease severity
was 1.9 ± 0.7 (± S.D.). The maximum was usually reached
within the first 3 days following disease manifestation (Figure
3B).
We normalized the ventricle volumes of each time point to
the baseline values (d -15) and plotted the changes in ventricle
size over the disease course (Figure 3C), similar to the weight
and score curves. The average mean size of the ventricles at
baseline was 10.7 ± 1.1 (± S.D.) mm3. In contrast to the non-
immunized control mice, the ventricle size of EAE animals
started to increase in size on average already two days before
clinical symptoms and in some cases expanding 2 times more
than baseline volume. For all EAE animals, we compared (i)
Figure 1.  Pre-symptomatic changes in ventricle size in an EAE mouse model.  (A) T2-weighted horizontal views of the mouse
brain show the evolution of changes in ventricle size of a representative mouse from baseline (pre EAE induction) 15 days prior
(d-15) to disease manifestation up till 4 days after disease manifestation (d +4). (B) Shown are 20 mice (1–20) exhibiting increase in
ventricle volume prior to or concurrent to disease onset. For each animal, gray bars represent the first occurrence of ventricle
enlargement and ensuing time points following EAE induction and black vertical lines indicate the symptom onset post
immunization. The animals were sorted according to the time difference between first changes in ventricle size (light gray bars) and
onset of clinical symptoms post immunization (black vertical lines). Mouse 1 exhibited ventricle enlargement 5 days prior to clinical
symptoms, Mouse 17 – Mouse 19 exhibited ventricle enlargement on the same day as clinical symptoms and Mouse 20 showed no
ventricle enlargement.
doi: 10.1371/journal.pone.0072841.g001
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disease severity and magnitude of ventricular enlargement
(Figure S2A), (ii) weight loss and magnitude of ventricular
enlargement (Figure S2B) and (iii) disease severity and onset
of ventricular enlargement (Figure S2C). However, we did not
observe any correlation between the onset or magnitude of
ventricular enlargement and the different clinical disease
measures.
Notably, in 3 EAE mice (8, 9 and 14 in Figure 1B), the
ventricle size started returning to normal values during disease
remission (Figure 3F). In these EAE mice a reduction in
ventricle size started on average 3 days after disease
manifestation, at the same time as the peak of symptoms, thus
preceding disease remission (Figure 3F). Although these three
mice showed a significant reduction in ventricle size during the
remission of the disease (in parallel to the increase in average
weight (Figure 3D), and a decrease in disease score (Figure
3E), we could not observe any significant differences in the
disease scores between these three cases and the rest of the
cohort.
Although the present findings occur at an early stage of
disease, several days prior to symptom onset, it remains to be
excluded that ventricle enlargement occurs as a consequence
of brain atrophy, i.e. cell death. Therefore, we followed
changes over time in the brain parenchyma volume in mice
within the ventricle non-normalizing group and those within the
ventricle normalizing group. In comparison to control mice, the
group of mice with sustained ventricular enlargement showed a
significant decrease in brain volume (Figure S3A), interestingly
after the time point showing significant enlargement in
ventricles (Figure 3C). In the ventricle normalizing animal
group, relative brain parenchymal volumes remained constant.
These results suggest that ventricular expansion may be
Figure 2.  Pre-symptomatic development of cerebellar lesion in an EAE mouse model.  (A) T2-weighted horizontal views of the
mouse cerebellum, which show the temporal progression of lesions in the arbor vitae of the cerebellum of a representative mouse
starting from pre EAE induction 15 days before clinical symptoms (baseline d-15) up till 2 days after disease manifestation (d +2);
stars highlights hyperintense lesion appearance, arrowheads points to the hypointense lesions. (B) Graph showing the first day
when cerebellar modifications were observed (gray bars) and the symptom onset (black vertical lines) for all animals in the study.
The x-axis indicates the time points after EAE induction (0). The animals were sorted according to the time difference between first
occurrence in cerebellar lesions and the onset of clinical symptoms post immunization. Mouse 1 exhibited cerebellar lesions 5 days
prior to clinical symptoms, Mouse 19 and Mouse 20 showed no cerebellar lesions.
doi: 10.1371/journal.pone.0072841.g002
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accompanied by compression of the brain parenchyma (Figure
S3B).
To investigate the possibility that mechanical obstruction
between the ventricles (e.g. due to lesion formation) could
explain the changes in ventricular volume we calculated the
size of each of all four ventricles independently and over time
(Figure 4). All ventricles showed a volume increase before the
symptom onset. However, the change in volume in the
combined lateral ventricles (Figure 4A), left ventricle alone
(Figure 4B) and right ventricle alone (Figure 4C) was much
more pronounced than the change in volume in the third
(Figure 4D) and fourth ventricle (Figure 4E).
In order to exclude the possibility of ventricular changes
occurring due to non-specific effects of the adjuvants used
during immunization [29], we immunized 6 mice following the
same protocol used for the EAE immunization but excluding
the PLP peptide. We followed these mice for 10 days after
immunization. We could not detect weight loss (Figure S4A),
disease symptoms (Figure S4B), changes in ventricle size
(Figure S4C) or occurrence of cerebellar lesions in these
animals during this time window.
Ventricle volume increase is related to changes in T2
relaxation time of cerebrospinal fluid
To investigate possible changes in water content in the
cerebrospinal fluid (CSF), we performed T2 relaxometry, which
correlates with methods of direct water content quantification in
the brain [20,21]. As shown in a representative mouse within
the group, a significant increase in T2 relaxation time of the
CSF also occurred at early stages of the disease and persisted
until after disease onset (Figure 5A). In order to compare the
changes in ventricle volume and changes in T2 relaxation time,
we pooled the data acquired on three consecutive days prior to
first clinical symptoms and data acquired during the three days
after first clinical symptoms, and compared the changes to age-
matched healthy control mice. These control animals were
measured in parallel to the EAE mice. When compared to the
ventricle size of control animals (volume = 12.7 ± 1.1 (± S.D.)
mm3), we observed a significant increase in ventricle size in
EAE mice prior to clinical disease onset and an even more
prominent increase following disease manifestation (Figure
5B). Also when comparing the CSF T2 relaxation times
between EAE and control mice, we observed an increase in
CSF T2 relaxation time both prior to (controls = 106.4 ± 5.83 (±
S.D.), EAE mice = 110.8 ± 4.18 (± S.D.), p = 0.0586) and
Figure 3.  Time-line for weight, score and ventricle volume during EAE development.  All the animals were weighed and
scored before EAE induction and daily starting from the day of immunization onwards. At baseline and then starting from day 5 after
EAE induction micro MRI measurements were performed and the ventricle volumes measured. Graph shows the temporal changes
in weight (A), score (B) and ventricle volume (C) for control mice (n=6) and EAE mice (n=20) synchronized to the first day of clinical
symptoms. (D) Weight, (E) score and (F) ventricle volume changes of EAE animals that showed remission in ventricle enlargement
(n=3) against control animals (n=6).
doi: 10.1371/journal.pone.0072841.g003
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following (controls = 107.3 ± 3.10 (± S.D.), EAE mice = 116 ±
4.29 (± S.D.), p = 0.0004) disease onset (Figure 5C).
Discussion
Studying the early processes during CNS inflammation is
important to gain a better insight into how immune cell invasion
may affect the autoimmune response. In this study we
identified an early ventricular enlargement prior to cerebral
disease manifestation in a mouse model of encephalomyelitis.
In the animal model, the increase in ventricular size was
accompanied by increased free water content in CSF as
demonstrated by increased T2 relaxation times in the CSF
compartment. In some EAE mice we observed a contraction in
ventricle size at the time between disease peak and prior to
remission, indicating a possible reversibility in the factor
contributing to enlargement of the ventricles. Likely as a
consequence to ventricular enlargement, in the group of
animals with sustained ventricular enlargement we observed a
decrease in brain parenchyma volume. In contrast, this finding
did not hold true in the ventricle normalizing animals. In the
non-normalizing animals the brain volume reduction occurred
after ventricle enlargement. Thus, we may exclude brain
atrophy as primary source of ventricular enlargement in our
study – a finding further supported by the very early time point
ventricular enlargement is detectable. Prior to the macroscopic
changes in the ventricles, we also detected microscopic
alterations in the brain parenchyma. Microscopic changes
involved evolving hyper- and hypo-intense regions in T2-
weighted images, particularly in the cerebellar white matter and
as early as three days before symptom onset. The latter is in
line with our first micro MRI study in EAE mice where we
corroborated using immunohistology the presence of hypo-
intense lesions in T2-weighted images to areas of immune cell
infiltration [19].
One possible explanation for the ventricular enlargement
could be an impediment in cerebral CSF flow resulting from a
physical obstruction at the interventricular foramen (Monro),
such as in obstructive hydrocephalus. We therefore measured
the changes in volume in all four ventricles to determine
whether the ventricles downstream of the lateral ventricles also
changed in size. The analysis of each separate ventricle
revealed that each ventricular compartment increased in size
prior to clinical symptom onset. Also a few days before disease
manifestation, we detected an increase in CSF water content
within the ventricles as reflected from the T2 relaxation time.
Several previous reports have demonstrated a linear
correlation between spin-spin relaxation time (T2)
measurements and ex vivo desiccation methods to quantify
tissue water content in brain [20,21] and other tissue [30]. As
Figure 4.  Changes in volume for the single ventricular compartments.  Shown is a graphical representation of the temporal
changes in volume for both lateral (A), left lateral (B), right lateral (C), third (D) and fourth (E) ventricles for all EAE (n=20) and
control (n=6) mice. All points represent a ratio of the daily ventricle volume to the ventricle volume prior to immunization (baseline
d-15) and are synchronized to the day of clinical disease onset.
doi: 10.1371/journal.pone.0072841.g004
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reference, in vitro modifications in water content from 70% to
85% were reported to change T2 relaxation time from 100 ms to
200 ms [20].
Our results appear to preclude the hypothesis that volume
increase in the ventricles could be the result of an obstruction
in one of the foramina connecting the ventricles. These results
Figure 5.  Pre- and post- symptomatic changes in ventricle size and cerebrospinal fluid T2 relaxation time.  (A) Maps
depicting the absolute T2 relaxation time (ms) prior to and after disease manifestation. (B) Values for the ventricle volume were
grouped into two groups for all EAE animals (3 days before and 3 days after first symptom) and compared with control animals.
Shown are the differences in ventricle volume between the control (CTRL) and EAE groups prior to (Pre (3d), p = 0.0180) and after
(Post (3d), p = 0.0003) disease onset. (C) Values for the CSF T2 relaxation time were also grouped as above and compared with
control animals. Shown are the differences in T2 relaxation times between the control (CTRL) and EAE groups prior to (Pre (3d), p =
0.0386) and after (Post (3d), p = 0.0002) disease manifestation.
doi: 10.1371/journal.pone.0072841.g005
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rather suggest that the increase in ventricular size could be
either the result of a dysregulation in CSF homeostasis (e.g. a
deficit in CSF reabsorption or an increase in CSF production).
Alternatively, a disruption of the tight junctions (TJ) of the BBB
and blood CSF barrier may increase the flux of solutes through
the barrier leading to fluid leakage into the CSF-filled
compartments. In this perspective it has been shown that an
alteration of BBB TJ proteins and changes in microcirculation,
associated with the presence of inflammatory cells, occur
during EAE and MS [13,31–33]. On the other hand, we recently
reported a contrast agent-enriched ventricular system in EAE
suggesting a leakage into the ventricles possibly via the blood
CSF barrier during disease [19]. Using a flow compensated
gradient echo technique, we observed an outflow of Gd-DTPA
into the ventricles of EAE but not healthy animals [19]. Either of
these possibilities suggests that ventricle size may serve as a
potential indicator of the level of inflammation in the CNS, even
prior to other more conventional measures (e.g. contrast
enhancing lesions).
Several CNS routes exist for CSF drainage that might be
involved in the communication with the lymphatic system. The
relevance of immune cell trafficking between the lymphatic
system and CNS has been described in models of
spontaneous EAE [34]. Important communication routes
include anatomical sites (such as the cribriform plate)
associated with lymphatics (eg. those associated with the
olfactory or other cranial nerves) [35]. Immune cells, including
memory CD4+ T cells, follow these communication routes
during autoimmune neuroinflammation [2]. More recently, it
was also shown that leukocytes infiltrate periventricular tissue
as well as perivascular spaces prior to clinical symptom onset
[36]. In agreement with this study, we have also recently shown
an extensive accumulation of inflammatory cells on the ventral
side of the forebrain, midbrain and brainstem as shown by
fluorine/proton MRI [37].
In all of our EAE cases, the fluctuations in ventricular volume
were relatively fast and cannot be explained by brain atrophy
that is a slow and gradual process occurring over several years
[38]. Furthermore, in a recent study with MS patients that were
followed up MRI for a period of 5 years after first diagnosis, the
percentage ventricular volume change was found to be higher
during the first 2 years compared to the ensuing 3 years [39].
The rate of early ventricular enlargement was also suggested
in this study to be more predictive of disease progression than
lesion measures or whole brain atrophy rate [39].
In summary, our present findings in the EAE model provide
first indications that the progression of encephalomyelitis is
accompanied by substantial fluctuations in ventricle size
already in the earliest stages of disease. Several mechanisms
could be involved in this observation, including a disruption in
CSF homeostasis or fluctuations in the edematous milieu of
inflammatory cells and their products. Further preclinical and
clinical investigations are warranted to elucidate the basis
leading to ventricular enlargement and to explore the
mechanisms and causative factors that could precipitate these
macroscopic changes during encephalomyelitis.
Supporting Information
Figure S1.  Overview of the pre-symptomatic brain
alterations.
(A) Shown are, for each animal, the first day of cerebellar
lesion appearance (p < 0.0001) and the first day of ventricle
enlargement (p < 0.0001) are shown, compared to the days of
symptom onset (n= 20). (B) Time-to-event curves to compare
the first occurrence of ventricle enlargement and cerebellar
lesions relative to clinical onset. Statistical significance:
cerebellar lesions vs. clinical signs, p < 0.0001; ventricular
enlargement vs. clinical signs, p = 0.0064.
(TIF)
Figure S2.  No relation between magnitude or occurrence
of ventricle enlargement and clinical disease measures.
(A) Comparison between disease severity and magnitude of
ventricular enlargement. (B) Comparison between weight loss
and magnitude of ventricular enlargement. (C) Comparison
between disease severity and occurrence of ventricular
enlargement.
(TIF)
Figure S3.  Time-line of changes in brain parenchyma
volume during EAE development.
Brain parenchyma was measured in slices depicting the
caudate putamen and lateral ventricles. The parenchymal
volumes for all animals were centered on day of symptom
onset. Temporal changes in the parenchymal volume of mice
with sustained ventricle enlargement (A) and parenchymal
volume of mice with normalizing ventricles (B) were compared
to controls.
(TIF)
Figure S4.  Timeline of weight and ventricle size and score
of sham immunized animals.
All the animals were weighed and scored before sham
immunization and daily thereafter. Micro MRI measurements
were performed at baseline and then from day 5 to day 10 after
sham immunization and the ventricle volumes measured.
Temporal changes in weight (A), score (B) and ventricle
volume (C) are shown (n=6).
(TIF)
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